Abstract3D cellular spheroids offer more biomimetic microenvironments than conventional 2D cell culture technologies, which has proven value for many tissue engineering applications. Despite the beneficiary effects of 3D cell culture, clinical translation of spheroid tissue engineering is challenged by the limited scalability of current methods of spheroid formation. Although the recent adoption of droplet microfluidics can provide a continuous production process, the use of oils and surfactants, the generally low throughput, and requirement of additional biofabrication steps hinder clinical translation of spheroid culture. Here we report on the use of clean (e.g., oil‐free and surfactant‐free), ultra‐high throughput (e.g., 8.5 ml/min, 10.000 spheroids/s), single‐step, in‐air microfluidic biofabrication of spheroid forming compartmentalized hydrogels. We demonstrated that this novel technique could reliably produce 1D, 2D, and 3D compartmentalized hydrogel constructs in the form of fibers, plane, and volumes, which each allowed for distinct (an)isotropic orientation of hollow spheroids forming compartments. The spheroids that were produced within ink‐jet bioprinted compartmentalized hydrogels outperformed 2D cell cultures in terms of chondrogenic behavior. Moreover, we demonstrated that the cellular spheroids could be harvested from compartmentalized hydrogels and used to build shape‐stable centimeter‐sized biomaterial‐free living tissues in a bottom‐up manner. Consequently, it is anticipated that in‐air microfluidic production of spheroid forming compartmentalized hydrogels could advance the production and use of cellular spheroids for various biomedical applications.This article is protected by copyright. All rights reserved